Bristol-Myers Squibb Co
XMUN:BRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bristol-Myers Squibb Co
XMUN:BRM
|
US |
|
M
|
Microsoft Corp
XMUN:MSF
|
US |
|
Humana Inc
NYSE:HUM
|
US |
|
A
|
Amphenol Corp
F:XPH
|
US |
|
C
|
Church & Dwight Co Inc
F:CXU
|
US |
|
K
|
Keurig Dr Pepper Inc
F:DP5
|
US |
|
Aeon Co Ltd
F:JUS1
|
JP |
|
Q
|
Qualcomm Inc
SIX:QCOM
|
US |
|
S
|
Schroders PLC
F:PYXA
|
UK |
|
A
|
Aptiv PLC
XMUN:D7A
|
IE |
|
E
|
Emerson Electric Co
XMUN:EMR
|
US |
|
E
|
Ecolab Inc
XBER:ECJ
|
US |
|
N
|
News Corp
F:NC0
|
US |
|
A
|
Advanced Micro Devices Inc
DUS:AMD
|
US |
Wall St Price Targets
BRM Price Targets Summary
Bristol-Myers Squibb Co
According to Wall Street analysts, the average 1-year price target for BRM is 58.81 EUR with a low forecast of 35.69 EUR and a high forecast of 74.21 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BRM's stock price target?
Price Target
58.81
EUR
According to Wall Street analysts, the average 1-year price target for BRM is 58.81 EUR with a low forecast of 35.69 EUR and a high forecast of 74.21 EUR.
What is the Revenue forecast for Bristol-Myers Squibb Co?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is -3%.
What is the Gross Profit forecast for Bristol-Myers Squibb Co?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 8 years is -2%.
What is the Operating Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is -2%.
What is the Pre-Tax Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 7%.
